Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treatment using modified FGF-21 polypeptides comprising non-naturally occurring amino acids

Methods of treatment using modified FGF-21 polypeptides comprising non-naturally occurring amino acids

US Patent 9517273 · Granted Dec 13, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of c-type natriuretic peptide variants to treat osteoarthritis2025
Anti-CD70 antibody drug conjugates2024
Conformationally stabilized RSV pre-fusion F proteins2024
Modified FGF-21 polypeptides with non-naturally encoded amino acids2024
Modified FGF-21 polypeptides with non-naturally encoded amino acids2024
Modified FGF-21 polypeptides with non-naturally encoded amino acids2024
Modified FGF-21 polypeptides with non-naturally encoded amino acids2024
Modified FGF-21 polypeptides with non-naturally encoded amino acids2024
Modified FGF-21 polypeptides with non-naturally encoded amino acids2024
Modified FGF-21 polypeptides with non-naturally encoded amino acids2024
Conformationally stabilized RSV pre-fusion F proteins2024
Modified relaxin polypeptides and their uses2023